Clinical Trial Site

El Palmar 30120

2 studies enrolling now · 3 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Hereditary Coproporphyria (HCP), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Porphyria, Acute Intermittent, Transthyretin Amyloidosis With Cardiomyopathy, Variegate Porphyria (VP)

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) — Completed